The effect of dextran for hypothermic (10°C) preservation of human fetal lung fibroblasts

Journal of Cardiovascular Surgery

Volumn 39, Issue 3, 1998, Pages 367-372

  Spaggiari, L ^a   Alfieri, R ^a   Carbognani, P ^a   Rusca, M ^a   Petronini, P ^a   Cattelani, L ^a   Bobbio, A ^a   Tecchio, T ^a   Borghetti, F A ^a   Bobbio, P ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Methods; Organ preservation

Indexed keywords

DEXTRAN; PROTEIN;

ARTICLE; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; CYTOTOXICITY; FETUS; FETUS LUNG; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MOLECULAR WEIGHT; ONCOTIC PRESSURE; OSMOLARITY; PROTEIN CONTENT; PROTEIN SYNTHESIS;

CELL SURVIVAL; DEXTRANS; FIBROBLASTS; HUMANS; LUNG; MOLECULAR WEIGHT; ORGAN PRESERVATION SOLUTIONS; OSMOLAR CONCENTRATION; TEMPERATURE; TISSUE PRESERVATION;

EID: 15444338956     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Fujimura S, Kondo T, Handa M, Yamauchi A, Okabe T, Shionozaki F et al. Successful 24-hour preservation of canine lung transplant using modified extracellular fluid. Transplant Proc 1985;17:1466-7.
2. Fujimura S, Handa M, Kondo T, Ichinose T, Shiraishi Y, Nakada T. Successful 48-hour simple hypothermic preservation of canine lung transplants. Transplant Proc 1987;19:1334-6.
3. Yamazaki F, Yokomise H, Keshavjee SH, Miyoshi S, Cardoso PF, Slutsky AS et al. The superiority of an extracellular fluid solution over Euro-Collins solution for pulmonary preservation. Transplantation 1990;49:690-4.
4. Maccherini M, Keshavjee SH, Slutsky AS, Patterson GA, Edelson JD. The effect of Low-Potassium-Dextran versus Euro-Collins solution for preservation of isolated type II pneumocytes. Transplantation 1991;52:621-6.
5. Keshavjee SH, Yamazaki F, Yokomise H, Cardoso PF, Mullen JBM, Slutsky AS et al. The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation. J Thorac Cardiovasc Surg 1992;103:314-24.
6. Keshavjee SH, McRitchie DI, Vittorini T, Rotsein OD, Sutsky AS, Patterson GA. Improved lung preservation with dextran 40 is not mediated by a Superoxide radical scavenging mechanism. J Thorac Cardiovasc Surg 1992;103:326-8.
7. Steen S, Kimblad PO, Sjoberg T, Lindberg L, Ingemansonn R, Massa G. Safe lung preservation for twenty-four hours with perfadex. Ann Thorac Surg 1994;57:450-7.
8. Ingemansson R, Massa G, Pandita RK, Sjoberg T, Steen S. Perfadex is superior to Euro-Collins solution regarding 24-hour preservation of vascular function. Ann Thorac Surg 1995;60:1210-4.
9. Spaggiari L, Bobbio P. Dextran 40 at 2% versus 5% in low-potassium solutions: which is best? Ann Thorac Surg 1994; 58:1784.
10. Spaggiari L, Carbognani P, Rusca M, Alfieri R, Urbani S, Cattelani L et al. Methodology for the assessment of lung protection. Transplantation 1995;60:1040-5.
11. Hint H. Relationship between the chemical and physiochemical properties of dextran and its pharmacological effects. In JR Derrick, MM Guest, editors.Dextrans: current concepts of basic actions and clinical applications. Springfield, Illinois: Charles C Thomas 1971:3-26
12. Spaggiari L, Carbognani P, Rusca M, Alfieri R, Petronini PG, Cattelani L et al. Some questions about EuroCollins solution used for lung preservation. J Cardiovasc Surg 1994;35(Suppl 1):149-52.